Annual Drug Patent Expirations for SUBOXONE Suboxone is a drug marketed by Indivior Inc and is included in two NDAs. It is available from one supplier. There are eight patents…
The post New patent expiration for Indivior Inc drug SUBOXONE appeared firs…
New patent expiration for Indivior Inc drug SUBOXONE Read Post »
[](//www.DrugPatentWatch.com/p/preview/generic-api/saxagliptin?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Saxagliptin is the generi…
New tentative approval for Amneal Pharms drug saxagliptin Read Post »
[](//www.DrugPatentWatch.com/p/preview/generic-api/eltrombopag?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Eltrombopag is the generi…
New tentative approval for Teva Pharms drug eltrombopag Read Post »
A strong patent portfolio is at the core of branded pharmaceutical firms. Accordingly, one way to assess the relative strength of pharmaceutical firms is to compare their patent-counts. This chart…
The post Which pharmaceutical companies have the large…
Which pharmaceutical companies have the largest patent portfolios? Read Post »
[](//www.DrugPatentWatch.com/p/preview/generic-api/saxagliptin?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Saxagliptin is the generi…
New tentative approval for Amneal Pharms drug saxagliptin Read Post »
[](//www.DrugPatentWatch.com/p/preview/generic-api/saxagliptin?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Saxagliptin is the generi…
New tentative approval for Amneal Pharms drug saxagliptin Read Post »
SUBOXONE (buprenorphine hydrochloride; naloxone hydrochloride) Indivior inc Patent: 10,285,910 Expiration: Oct 11, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,…
The post Drug…
Drug Patent Expirations for the Week of October 9, 2022 Read Post »
SUBOXONE (buprenorphine hydrochloride; naloxone hydrochloride) Indivior inc Patent: 10,285,910 Expiration: Oct 11, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,…
The post Drug…
Drug Patent Expirations for the Week of October 9, 2022 Read Post »
[](//www.DrugPatentWatch.com/p/preview/generic-api/eltrombopag?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Eltrombopag is the generi…
New tentative approval for Teva Pharms drug eltrombopag Read Post »
[](//www.DrugPatentWatch.com/p/preview/generic-api/eltrombopag?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Eltrombopag is the generi…
New tentative approval for Teva Pharms drug eltrombopag Read Post »
Get new actionable insights and updates from BiotechBlog
